Raised $120M across disclosed rounds.[1][6][13]

Series C closed June 2025, led by HV Capital.[1][2][13]

post-money valuation is not publicly disclosed.

Named investors include HV Capital, Highland Europe, DST Global, Cathay Innovation, Build Collective, ZEBOX Ventures.[1][4][13]

Alexandre Lebrun, Co-founder & CEO[2][4][13][17][18]

Delphine Groll, Co-founder & COO[2][4][13][17][18]

Martin Raison, Co-founder & CTO[2][4][13][17][18]

Dr. Ed Lee, Chief Medical Officer[5]